Business Description
![Conmed Corp Conmed Corp logo](https://static.gurufocus.com/logos/0C00000APC.png?14)
Conmed Corp
NAICS : 334510
SIC : 3845
ISIN : US2074101013
Share Class Description:
CNMD: Ordinary SharesDescription
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 1.16 | |||||
Debt-to-EBITDA | 4.61 | |||||
Interest Coverage | 3.65 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.18 | |||||
Beneish M-Score | -2.51 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.5 | |||||
3-Year EBITDA Growth Rate | 15 | |||||
3-Year EPS without NRI Growth Rate | 120.9 | |||||
3-Year FCF Growth Rate | 24.4 | |||||
3-Year Book Growth Rate | 3.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 24.4 | |||||
Future 3-5Y Total Revenue Growth Rate | 7.2 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.49 | |||||
9-Day RSI | 57.79 | |||||
14-Day RSI | 56.31 | |||||
6-1 Month Momentum % | -34.61 | |||||
12-1 Month Momentum % | -44.06 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.18 | |||||
Quick Ratio | 1.08 | |||||
Cash Ratio | 0.12 | |||||
Days Inventory | 209.13 | |||||
Days Sales Outstanding | 66.91 | |||||
Days Payable | 54.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.07 | |||||
Dividend Payout Ratio | 0.23 | |||||
Forward Dividend Yield % | 1.07 | |||||
5-Year Yield-on-Cost % | 1.07 | |||||
3-Year Average Share Buyback Ratio | -2.1 | |||||
Shareholder Yield % | 2.33 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 54.92 | |||||
Operating Margin % | 11.33 | |||||
Net Margin % | 6.53 | |||||
FCF Margin % | 11.22 | |||||
ROE % | 10.25 | |||||
ROA % | 3.56 | |||||
ROIC % | 5.15 | |||||
ROC (Joel Greenblatt) % | 33.87 | |||||
ROCE % | 7.2 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 28.64 | |||||
PE Ratio without NRI | 21.86 | |||||
Shiller PE Ratio | 68.58 | |||||
Price-to-Owner-Earnings | 18.27 | |||||
PS Ratio | 1.84 | |||||
PB Ratio | 2.69 | |||||
Price-to-Free-Cash-Flow | 16.65 | |||||
Price-to-Operating-Cash-Flow | 14.87 | |||||
EV-to-EBIT | 23.14 | |||||
EV-to-Forward-EBIT | 24.24 | |||||
EV-to-EBITDA | 15.39 | |||||
EV-to-Forward-EBITDA | 16.5 | |||||
EV-to-Revenue | 2.62 | |||||
EV-to-Forward-Revenue | 3.66 | |||||
EV-to-FCF | 23.39 | |||||
Price-to-Projected-FCF | 1.75 | |||||
Price-to-Median-PS-Value | 0.78 | |||||
Earnings Yield (Greenblatt) % | 4.32 | |||||
FCF Yield % | 6.15 | |||||
Forward Rate of Return (Yacktman) % | -7.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:CNMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Conmed Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1,261.548 | ||
EPS (TTM) ($) | 2.61 | ||
Beta | 0.91 | ||
Volatility % | 36.37 | ||
14-Day RSI | 56.31 | ||
14-Day ATR ($) | 2.033324 | ||
20-Day SMA ($) | 75.019 | ||
12-1 Month Momentum % | -44.06 | ||
52-Week Range ($) | 61.05 - 138.47 | ||
Shares Outstanding (Mil) | 30.8 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Conmed Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Conmed Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Conmed Corp Frequently Asked Questions
What is Conmed Corp(CNMD)'s stock price today?
The current price of CNMD is $74.75. The 52 week high of CNMD is $138.47 and 52 week low is $61.05.
When is next earnings date of Conmed Corp(CNMD)?
The next earnings date of Conmed Corp(CNMD) is 2024-07-26 Est..
Does Conmed Corp(CNMD) pay dividends? If so, how much?
The Dividend Yield %  of Conmed Corp(CNMD) is 1.07% (As of Today), Highest Dividend Payout Ratio of Conmed Corp(CNMD) was 2.5. The lowest was 0.23. And the median was 0.69. The  Forward Dividend Yield % of Conmed Corp(CNMD) is 1.07%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |